Sichenzia Ross Friedman Ference LLP Advises Amarantus on $5M PIPE Investment from Discover Growth Fund
New York, NY – April 29, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on developing diagnostics in neurology, and therapeutic products in the areas of neurology, psychiatry, ophthalmology and orphan diseases, on a $5 million investment from Discover Growth Fund.
Pursuant to the transaction’s Stock Purchase Agreement, Amarantus issued 1,087 shares of designated Series G Preferred stock at a fixed price of $0.06 per share for gross proceeds of $5,000,000. The Sichenzia Ross Friedman Ference LLP team was led by Partners Jeffrey J. Fessler and Marcelle Balcombe.
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference LLP代表Aegis Capital进行450万美元的Avinger，Inc.普通股的后续发行 - February 4, 2020
- Sichenzia Ross Ference LLP代表A.G.P.发行220万美元普通股 - January 31, 2020
- Sichenzia Ross Ference LLP代表匈牙利风险投资公司HiVentures Zrt。私下配售ActiveGraf的A股优先股 - January 16, 2020